Page last updated: 2024-10-24

carmustine and Adenoma

carmustine has been researched along with Adenoma in 2 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Adenoma: A benign epithelial tumor with a glandular organization.

Research Excerpts

ExcerptRelevanceReference
"To collect outcome data in a large cohort of patients with aggressive pituitary tumours (APT)/carcinomas (PC) and specifically report effects of temozolomide (TMZ) treatment."3.88Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016. ( Burman, P; Dekkers, OM; McCormack, A; Petersenn, S; Popovic, V; Raverot, G; Trouillas, J, 2018)
"Ten patients, nine with pituitary adenomas and one with a craniopharyngioma, underwent implantation of from two to eight Gliadel wafers."2.71Gliadel for pituitary adenomas and craniopharyngiomas. ( Laws, ER; Maartens, N; Morris, AM, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McCormack, A1
Dekkers, OM1
Petersenn, S1
Popovic, V1
Trouillas, J1
Raverot, G1
Burman, P1
Laws, ER1
Morris, AM1
Maartens, N1

Trials

1 trial available for carmustine and Adenoma

ArticleYear
Gliadel for pituitary adenomas and craniopharyngiomas.
    Neurosurgery, 2003, Volume: 53, Issue:2

    Topics: Adenoma; Adult; Aged; Antineoplastic Agents, Alkylating; Carmustine; Craniopharyngioma; Drug Carrier

2003

Other Studies

1 other study available for carmustine and Adenoma

ArticleYear
Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016.
    European journal of endocrinology, 2018, Volume: 178, Issue:3

    Topics: Adenoma; Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemoth

2018